Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates

The COVID-19 pandemic has exemplified that rigorous evaluation in large animal models is key for translation from promising in vitro results to successful clinical implementation. Among the drugs that have been largely tested in clinical trials but failed so far to bring clear evidence of clinical e...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlin, Romain, Desjardins, Delphine, Contreras, Vanessa, Lingas, Guillaume, Solas, Caroline, Roques, Pierre, Naninck, Thibaut, Pascal, Quentin, Behillil, Sylvie, Maisonnasse, Pauline, Lemaitre, Julien, Kahlaoui, Nidhal, Delache, Benoit, Pizzorno, Andrés, Nougairede, Antoine, Ludot, Camille, Terrier, Olivier, Dereuddre-Bosquet, Nathalie, Relouzat, Francis, Chapon, Catherine, Ho Tsong Fang, Raphael, van der Werf, Sylvie, Rosa Calatrava, Manuel, Malvy, Denis, de Lamballerie, Xavier, Guedj, Jeremie, Le Grand, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427089/
https://www.ncbi.nlm.nih.gov/pubmed/36042198
http://dx.doi.org/10.1038/s41467-022-32565-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427089/
https://www.ncbi.nlm.nih.gov/pubmed/36042198
http://dx.doi.org/10.1038/s41467-022-32565-w

Ejemplares similares